Phase III study comparing tacrolimus (FK506) with cyclosporine (CSP) for prophylaxis of acute graft-versus-host disease (GVHD) after marrow transplantation from unrelated donors.

被引：0
|
作者：
Nash, RA
Antin, J
Karanes, C
Fay, J
Avalos, B
Yeager, AM
Przepiorka, D
Davies, S
Petersen, F
Buell, D
Fitzsimmons, W
Bartels, P
Hansen, J
Anasetti, C
Storb, R
Ratanatharathorn, V
机构：
[1] FRED HUTCHINSON CANC RES CTR,BOSTON,MA
[2] BAYLOR UNIV,MED CTR,WAYNE STATE HOSP,WACO,TX 76798
[3] OHIO STATE UNIV,COLUMBUS,OH 43210
[4] EMORY UNIV,ATLANTA,GA 30322
[5] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
[6] UNIV UTAH,SALT LAKE CITY,UT 84112
[7] UNIV MICHIGAN,ANN ARBOR,MI 48109
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2499 / 2499
页数：1
相关论文
共 50 条
  • [21] Prophylaxis of graft-versus-host disease (GVHD) with tacrolimus and methotrexate after allogeneic bone marrow transplantation (BMT) from unrelated donor: Impact of blood level of tacrolimus on the development of acute GVHD
    Mori, T
    Nakazato, T
    Aisa, Y
    Yamazaki, R
    Ikeda, Y
    Okamoto, S
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 65 - 65
  • [22] FK506 (TACROLIMUS) IN THE TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION
    KOEHLER, MT
    HOWRIE, D
    MIRRO, J
    NEUDORF, S
    BLATT, J
    COREY, S
    WOLLMAN, M
    KELLYEKEROTH, V
    REYES, J
    BONE MARROW TRANSPLANTATION, 1995, 15 (06) : 895 - 899
  • [23] FK 506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER UNRELATED DONOR MARROW TRANSPLANTATION
    FAY, JW
    NASH, RA
    WINGARD, JR
    PRZEPIORKA, D
    COLLINS, RH
    ANASETTI, C
    DEVINE, SM
    PINEIRO, LA
    STORB, RF
    ARO, RM
    FITZSIMMONS, WE
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (01) : 1374 - 1374
  • [24] Risk factors of acute graft-versus-host disease (AGVHD) after allogeneic bone marrow transplantation using an matched unrelated donor (MUD) and prophylaxis with taclorimus (FK506) and methotrexate (MTX)
    Iguchi, T
    Okamoto, S
    Mori, T
    Watanabe, R
    Sato, N
    Nagayama, H
    Takayama, N
    Ikeda, Y
    BONE MARROW TRANSPLANTATION, 2002, 29 : S172 - S173
  • [25] Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation
    C Yu
    K Seidel
    WE Fitzsimmons
    G Sale
    R Storb
    Bone Marrow Transplantation, 1997, 20 : 137 - 141
  • [26] Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation
    Yu, C
    Seidel, K
    Fitzsimmons, WE
    Sale, G
    Storb, R
    BONE MARROW TRANSPLANTATION, 1997, 20 (02) : 137 - 141
  • [27] Glucocorticoids failed to enhance the effect of FK506 and methotrexate (MTX) on prevention of graft-versus-host disease (GVHD) after DLA-nonidentical, unrelated canine marrow transplantation.
    Yu, C
    Storb, R
    Deeg, HJ
    Fitzsimmons, WE
    Sale, G
    BLOOD, 1996, 88 (10) : 3654 - 3654
  • [28] FK506 TREATMENT OF GRAFT-VERSUS-HOST DISEASE DEVELOPING OR EXACERBATING DURING PROPHYLAXIS AND THERAPY WITH CYCLOSPORINE AND/OR OTHER IMMUNOSUPPRESSANTS
    KANAMARU, A
    TAKEMOTO, Y
    KAKISHITA, E
    DOHY, H
    KODERA, Y
    MORIYAMA, Y
    SHIBATA, A
    KASAI, M
    KATOH, S
    SAITOH, H
    MATSUDA, T
    HATTORI, M
    OKAMOTO, S
    ASANO, S
    HORIUCHI, A
    HARADA, M
    HIRAOKA, A
    MASAOKA, T
    BONE MARROW TRANSPLANTATION, 1995, 15 (06) : 885 - 889
  • [29] TACROLIMUS (FK506) ALONE OR IN COMBINATION WITH METHOTREXATE OR METHYLPREDNISOLONE FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER MARROW TRANSPLANTATION FROM HLA-MATCHED SIBLINGS - A SINGLE-CENTER STUDY
    NASH, RA
    ETZIONI, R
    STORB, R
    FURLONG, T
    GOOLEY, T
    ANASETTI, C
    APPELBAUM, FR
    DONEY, K
    MARTIN, P
    SLATTERY, J
    SULLIVAN, K
    VANDERJAGT, R
    WITHERSPOON, R
    JUSKO, WJ
    ZAGER, RA
    DEEG, HJ
    BLOOD, 1995, 85 (12) : 3746 - 3753
  • [30] TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION - RANDOMIZED STUDY COMPARING CORTICOSTEROIDS AND CYCLOSPORINE
    KENNEDY, MS
    DEEG, HJ
    STORB, R
    DONEY, K
    SULLIVAN, KM
    WITHERSPOON, RP
    APPELBAUM, FR
    STEWART, P
    SANDERS, J
    BUCKNER, CD
    MARTIN, P
    WEIDEN, P
    THOMAS, ED
    AMERICAN JOURNAL OF MEDICINE, 1985, 78 (06): : 978 - 983
12345